|
Vol. 7, No. 1: January 2008 - EXECUTIVE SUMMARY
Welcome to this issue of Pharma Marketing News. Subscribe Now to get the current and future issues FREE!
Order and pay for this ENTIRE ISSUE now using your credit card...
ONLY $12.95
Download PDF file immediately after paying:
CONTENTS
Article Summaries
| Use of Celebrities for PR and DTC Advertising |
"Break a Leg," But Avoid Pratfalls!
Congress is investigating the use of celebrity endorsements in pharmaceutical advertising and recently sent a letter to Pfizer questioning if the use of Dr. Robert Jarvik, a physician and inventor of the Jarvik artificial heart, is misleading consumers. At issue is the fact that Jarvik has never held a license to practice medicine in any state.
If you have questions about the "dos & don'ts" and "pros & cons" of using medical and non-medical mouthpieces for pharma PR and DTC advertising, this article may have some answers based on interviews of experts with years of experience in this area.
Topics and issues covered include:
- Celebrity Endorsements: Clear and Prominent Disclosure
- Congress Probes Celebrities
- When Celebrities Go Bad
- Prepare Your Celebrities for Media Interviews
- Bloggers Weigh In on Montel and Jarvik
- Includes comments from Pharma Marketing Roundtable members
Order and pay for this reprint now using your credit card...
ONLY $6.95
Download PDF file immediately after paying:
| Pharma Marketing Network 2007 Report |
Stats and Subscriber Profiles
Pharma Marketing Network is a leading online resource for pharmaceutical marketers, bringing together into a single online community pharmaceutical marketing, advertising, and sales professionals from pharmaceutical companies, communications companies, and marketing service providers.
The Pharma Marketing News newsletter is the linchpin of the Network, which also includes an online discussion and social networking Forum site (see "An Online Community of Our Own"), Pharma Marketing Blog, and an informational Web portal site packed with resources for marketers.
This report provides information about our subscribers and Web site statistics for 2007.
Topics and issues covered include:
- Pharma Marketing News: Types of articles, subscriber profile
- Portal Site: Subdomains, site statistics
- Pharma Marketing Network Forums: site statistics
- Pharma Marketing Blog: Reader survey results, statistics
- Pharma Marketing Talk
- Pharma Marketing Vendor Directory
FREE Full-Text Reprint Available
Click Here for PDF File.
New Rules for Industry Support
Last year, the pharmaceutical industry provided $1.19 billion to sponsor CME programs ($1.44 billion if you include advertising and exhibits at CME events). That's about 60% of all sources of funding for CME reported by ACCME.
A task force of the American Psychological Association (APA) recently recommended that its 148,000 members "turn their nose up at pharma funds; limit the role industry plays at professional conferences, meetings and CME sessions; and adopt strict guidelines on conflict-of-interest disclosure."
Congress continues to examine pharma industry support of CME and ACCME has issued some new guidance for accredited CME providers.
This article examines the current state of industry support for CME and what reforms may be coming down the pike.
Topics and issues covered include:
- Impact on MECCs
- Influence Within Medical Schools
- What About Physician Societies?
- Fixing the "Problem"
- Virtually Free CME?
- The CME Evolutionary Horizon
Order and pay for this reprint now using your credit card...
ONLY $9.95
Download PDF file immediately after paying:
| Is It Time to End Industry Sponsored CME? |
Survey Results
Since 17 December 2007, Pharma Marketing News has hosted an online survey (access it here) asking respondents their views regarding industry sponsorship of accredited CME, including views on value, bias, ACCME firewalls, and alternative means of CME support. We present some preliminary results in this summary.
Topics and issues covered include:
- About Respondents
- Views on Industry-Sponsored CME
- Views of Segments: Accredited Organizations and Pharmacos
FREE Full-Text Reprint Available
Click Here for PDF File.
| Cholesterol Drug Users Discuss Their Medication |
Talking Health at a Local Coffee Shop
At breakfast recently in one of his favorite coffee shops, Jim Avery, professor of advertising at the University of Oklahoma, was talking with some friends who he knew had some health problems. Avery mentioned that there were a couple of recent articles in newspapers on cholesterol drugs and clinical trials. No one had seen or even heard of these articles and Avery was a bit taken aback that he was the only one who had seen what he judged to be fairly important information on healthcare.
Avery took the opportunity to turn the breakfast meeting into a little impromptu focus group. This article summarizes what he learned.
Topics and issues covered include:
- Cholesterol Treatment in the News
- Surprising Lack of Trust
- Should I Stop Taking Zetia?
- Surrogate Endpoints "Miss the Point"
- FDA Not Doing Its Job?
Order and pay for this reprint now using your credit card...
ONLY $4.95
Download PDF file immediately after paying:
###
PHARMA MARKETING NEWS AD POLICY
We accept advertising relevant to the interests of our subscribers. All ads are approved by the Editor.
The monthly e-mail version of Pharma Marketing News is supported by sponsorship ads embedded within the e-mail newsletter (see above).
The full PDF version of the monthly newsletter accepts quarter page and half page ads.
E-mail Ads also are sent to subscribers as separate "AD SUPPLEMENTS" in between issues of the newsletter. Subscribers have given permission to receive these e-mail ads
as a condition for a free subscription to the newsletter.
Only a limited number of e-mail ads deemed relevant to subscribers are accepted.
The subject line of each e-mail ad accurately reflects the content of the ad.
If you are interested in sponsoring an issue of Pharma Marketing News, placing an ad in the PDF version of the newsletter, or sending an e-mail ad to our subscribers,
please call us at 215-504-4164, or email
(sales@pharma-mkting.com).
Do not reply to this message to respond to the Ad. Please respond
using the contact information at the end of the Ad copy above.
Copyright © 2008. VirSci Corporation. All rights reserved.
|
|
|
|
We'd like your answers to the following and a few other questions:
- Do you find Pharma Marketing News essential for keeping up with trends and ideas in pharmaceutical marketing?
- Is the newsletter well written?
- Do the display advertisements within the newsletter provide useful information?
- What about the email ad supplements sent separately?
- What topics related to pharmaceutical marketing and sales are you most interested in?
- Which other industry trade publications or newsletters do you subscribe to and/or read on a regular basis?
Take just 5 minutes to respond to this online survey and as thank you, we will give you special discounts on Reprint Supplements focused on these topics:
- eDetailing
- Physician Education
- Sales Force Effectiveness
- ePharma Marketing
- DTC Advertising (Vol 1 and Vol 2)
Access the Online Survey Here!
Archived:
 The Messenger is the Medium
The do's and don'ts of using celebrities as pharma spokespeople in ads and promotional campaigns. A conversation with Rich Benci, president of RealAge.
More info here...
Listen Online
 WAX Audio File for Windows Media Player
PHARMA MARKETING NEWS
www.pharmamarketingnews.com
Published by VirSci Corp.
PO Box 760
281 Stanford Place
Newtown, PA 18940-0760
www.virsci.com
Pharma Marketing News is the monthly e-newsletter of the Pharma
Marketing Network(www.pharma-mkting.com). Pharma Marketing Network
is an exclusive marketing information resource and communications
network for pharmaceutical marketing professionals. The Network
includes an interactive e-mail discussion group (PHARMA-MKTING),
an informational web site, and a monthly newsletter (Pharma
Marketing News).
Each issue of Pharma Marketing News is packed with facts,
opinions, and case studies based upon interviews with experts in
the field of pharmaceutical marketing. Highlights of presentations
from industry conferences, contact lists for experts consulted,
and links to references help subscribers keep up to date on best
practices and network with their peers.
Do you wish to contribute an article? E-mail John Mack, editor of
PHARMA MARKETING NEWS
,
at editor@news.pharma-mkting.com.
Please see Author Guidelines for instructions.
|
